Cargando…
An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency
BACKGROUND: Although there are many different expression systems for recombinant production of pharmaceutical proteins, many of these suffer from drawbacks such as yield, cost, complexity of purification, and possible contamination with human pathogens. Microalgae have enormous potential for diverse...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503769/ https://www.ncbi.nlm.nih.gov/pubmed/22970838 http://dx.doi.org/10.1186/1475-2859-11-126 |
_version_ | 1782250504439463936 |
---|---|
author | Hempel, Franziska Maier, Uwe G |
author_facet | Hempel, Franziska Maier, Uwe G |
author_sort | Hempel, Franziska |
collection | PubMed |
description | BACKGROUND: Although there are many different expression systems for recombinant production of pharmaceutical proteins, many of these suffer from drawbacks such as yield, cost, complexity of purification, and possible contamination with human pathogens. Microalgae have enormous potential for diverse biotechnological applications and currently attract much attention in the biofuel sector. Still underestimated, though, is the idea of using microalgae as solar-fueled expression system for the production of recombinant proteins. RESULTS: In this study, we show for the first time that completely assembled and functional human IgG antibodies can not only be expressed to high levels in algal systems, but also secreted very efficiently into the culture medium. We engineered the diatom Phaeodactylum tricornutum to synthesize and secrete a human IgG antibody against the Hepatitis B Virus surface protein. As the diatom P. tricornutum is not known to naturally secrete many endogenous proteins, the secreted antibodies are already very pure making extensive purification steps redundant and production extremely cost efficient. CONCLUSIONS: Microalgae combine rapid growth rates with all the advantages of eukaryotic expression systems, and offer great potential for solar-powered, low cost production of pharmaceutical proteins. |
format | Online Article Text |
id | pubmed-3503769 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35037692012-11-22 An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency Hempel, Franziska Maier, Uwe G Microb Cell Fact Research BACKGROUND: Although there are many different expression systems for recombinant production of pharmaceutical proteins, many of these suffer from drawbacks such as yield, cost, complexity of purification, and possible contamination with human pathogens. Microalgae have enormous potential for diverse biotechnological applications and currently attract much attention in the biofuel sector. Still underestimated, though, is the idea of using microalgae as solar-fueled expression system for the production of recombinant proteins. RESULTS: In this study, we show for the first time that completely assembled and functional human IgG antibodies can not only be expressed to high levels in algal systems, but also secreted very efficiently into the culture medium. We engineered the diatom Phaeodactylum tricornutum to synthesize and secrete a human IgG antibody against the Hepatitis B Virus surface protein. As the diatom P. tricornutum is not known to naturally secrete many endogenous proteins, the secreted antibodies are already very pure making extensive purification steps redundant and production extremely cost efficient. CONCLUSIONS: Microalgae combine rapid growth rates with all the advantages of eukaryotic expression systems, and offer great potential for solar-powered, low cost production of pharmaceutical proteins. BioMed Central 2012-09-13 /pmc/articles/PMC3503769/ /pubmed/22970838 http://dx.doi.org/10.1186/1475-2859-11-126 Text en Copyright ©2012 Hempel and Maier; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Hempel, Franziska Maier, Uwe G An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency |
title | An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency |
title_full | An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency |
title_fullStr | An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency |
title_full_unstemmed | An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency |
title_short | An engineered diatom acting like a plasma cell secreting human IgG antibodies with high efficiency |
title_sort | engineered diatom acting like a plasma cell secreting human igg antibodies with high efficiency |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503769/ https://www.ncbi.nlm.nih.gov/pubmed/22970838 http://dx.doi.org/10.1186/1475-2859-11-126 |
work_keys_str_mv | AT hempelfranziska anengineereddiatomactinglikeaplasmacellsecretinghumaniggantibodieswithhighefficiency AT maieruweg anengineereddiatomactinglikeaplasmacellsecretinghumaniggantibodieswithhighefficiency AT hempelfranziska engineereddiatomactinglikeaplasmacellsecretinghumaniggantibodieswithhighefficiency AT maieruweg engineereddiatomactinglikeaplasmacellsecretinghumaniggantibodieswithhighefficiency |